Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Robinson

Showing results (1111-1120 of 1,209) with videos related to

Pageof 121
Sort By:
Oxford Open Immunology|January 23, 2026
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patientsNicola Principe, Kofi L P Stevens, Amber-Lee Phung, et al.
Nature Genetics|February 10, 2015
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing lossHeng Xu, Giles W Robinson, Jie Huang, et al.
Pilot and Feasibility Studies|June 20, 2020
A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility studyMariana Murea, Randolph L Geary, Denise K Houston, et al.
Acta Neuropathologica|June 11, 2020
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resourceKyle S Smith, Ke Xu, Kimberly S Mercer, et al.
Neuro-Oncology Advances|January 28, 2021
Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trialAnthony P Y Liu, Gang Wu, Brent A Orr, et al.
Neuro-Oncology|March 22, 2025
Ototoxicity and Cognitive Outcomes among Very Young Children Treated for Brain Tumors: Findings from a Multisite, Prospective, Longitudinal TrialHeather M Conklin, Nicole A Salman, Johnnie K Bass, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2025
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusionsAmi V Desai, Aditi Bagchi, Amy E Armstrong, et al.
Neuro-Oncology|April 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastomaAlexa N Siskar, Emily Hanzlik, Maria F Cardenas, et al.
Contemporary Clinical Trials Communications|April 25, 2019
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study designMariana Murea, Randolph L Geary, Matthew S Edwards, et al.
Pageof 121

Showing results (1111-1120 of 1,209) with videos related to

Sort By:
Pageof 121
Oxford Open Immunology|January 23, 2026
Comparative analysis of malignant pleural effusion and peripheral blood reveals unique T cell signatures associated with survival in mesothelioma patientsNicola Principe, Kofi L P Stevens, Amber-Lee Phung, et al.
Nature Genetics|February 10, 2015
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing lossHeng Xu, Giles W Robinson, Jie Huang, et al.
Pilot and Feasibility Studies|June 20, 2020
A randomized pilot study to evaluate graft versus fistula vascular access strategy in older patients with advanced kidney disease: results of a feasibility studyMariana Murea, Randolph L Geary, Denise K Houston, et al.
Acta Neuropathologica|June 11, 2020
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resourceKyle S Smith, Ke Xu, Kimberly S Mercer, et al.
Neuro-Oncology Advances|January 28, 2021
Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trialAnthony P Y Liu, Gang Wu, Brent A Orr, et al.
Neuro-Oncology|March 22, 2025
Ototoxicity and Cognitive Outcomes among Very Young Children Treated for Brain Tumors: Findings from a Multisite, Prospective, Longitudinal TrialHeather M Conklin, Nicole A Salman, Johnnie K Bass, et al.
Clinical Lung Cancer|January 9, 2024
Plunging Into the PACIFIC: Outcomes of Patients With Unresectable KRAS-Mutated Non-Small Cell Lung Cancer Following Definitive Chemoradiation and Durvalumab ConsolidationAdam Barsouk, Cole Friedes, Michelle Iocolano, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2025
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusionsAmi V Desai, Aditi Bagchi, Amy E Armstrong, et al.
Neuro-Oncology|April 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastomaAlexa N Siskar, Emily Hanzlik, Maria F Cardenas, et al.
Contemporary Clinical Trials Communications|April 25, 2019
A randomized pilot study comparing graft-first to fistula-first strategies in older patients with incident end-stage kidney disease: Clinical rationale and study designMariana Murea, Randolph L Geary, Matthew S Edwards, et al.
Pageof 121